Thanks for your feedback, this will help us improve our content for you!
MASCC 2016 | Phase 1 clinical trial focused on safety of probiotics in cancer patients with mucositis
Matthew Ciorba, MD of Washington University School of Medicine in St. Louis, St. Louis, MO discusses mucositis prevention using probiotics. A phase 1 clinical trial focused on safety of probiotics in cancer patients uses Lactobacillus bacterial strain, which was shown to be effective in mucositis prevention in animal models. Dr Ciorba describes freeze-dried pills containing bacteria, which is a preferred option of probiotic delivery to the gut, as the purity and potency is more certain compared to a yogurt based product. Recorded at the Multinational Association of Supportive Care in Cancer (MASCC) and International Society of Ocular Oncology (ISOO) 2016 Annual Meeting on Supportive Care in Cancer held in Adelaide, Australia.